12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Company News  |  Other News

Sun Pharmaceutical, Teva, Watson, Apotex, Aurobindo, AstraZeneca, Glenmark, Mylan, Par Pharmaceutical, Torrent, Brigham and Women's Hospital Inc. cardiovascular

The U.S. Court of Appeals for the Federal Circuit affirmed a lower court's decision to dismiss a consolidated appeal from AstraZeneca and the hospital of nine suits in which AstraZeneca alleged the generic manufacturers' ANDA submissions infringed its method-of-use patents for cardiovascular drug Crestor rosuvastatin. In December 2010, the U.S. District Court for the District of Delaware court dismissed the cases for lack of...

Read the full 301 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >